- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
SonoSite’s NanoMaxx Enters U.S.
The FDA has given SonoSite the go-ahead to begin marketing its new NanoMaxx ultrasound system. The company said U.S. customer deliveries will begin shipping immediately.
SonoSite’s NanoMaxx Enters U.S.
The FDA has given SonoSite the go-ahead to begin marketing its new NanoMaxx ultrasound system. The company said U.S. customer deliveries will begin shipping immediately. International deliveries began in June. Featuring one-button optimization technology, the six pound NanoMaxx system will be marketed as a point-of-care system to hospitals and physician offices. The system, which boots up in less than 20 seconds, comes with five transducers to support thoracic assessment for pathology, vascular access, and needle aspirations and injections, as well as abdominal, cardiac, nerve, OB/Gyn, musculoskeletal, small parts and vascular scanning. NanoMaxx can be wall mounted, placed on an exam table with kickstand attached, used from a floor-based stand, or hand carried.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
